China Life Insurance Company (2628) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Oct, 2025Executive summary
Achieved robust business growth and operational improvements, with significant increases in scale, value, and efficiency across core insurance and investment activities.
Maintained a leading market position, with a stable and improving sales force and enhanced profitability.
Financial highlights
Total assets reached RMB7,417,981 million, up 9.6% from end-2024; equity attributable to shareholders rose 22.8% to RMB625,828 million.
Operating income for the first nine months was RMB537,895 million, up 25.9% year-over-year; net profit attributable to shareholders was RMB167,804 million, up 60.5%.
Gross written premiums for the first three quarters were RMB669,645 million, up 10.1% year-over-year.
Gross investment income reached RMB368,551 million, up 41.0% year-over-year; gross investment yield was 6.42%, up 104 basis points.
Earnings per share for the nine months was RMB5.94, up 60.5% year-over-year.
Outlook and guidance
Will continue to prioritize business value, profitability, long-term development, asset-liability interaction, and risk mitigation to achieve full-year targets and conclude the 14th Five-Year Plan.
Latest events from China Life Insurance Company
- Net profit dropped 32.3% year-over-year despite record growth in new business premiums.2628
Q1 2026 - Net profit surged 44.1% to RMB154.1 billion, with record assets and robust premium growth.2628
H2 2025 - Net profit surged 39.5% year-over-year, with premiums and solvency ratios both rising.2628
Q1 2025 - Record premiums and profit growth, high solvency, and interim dividend proposed.2628
H1 2025 - Net profit soared 173.9% year-over-year on record premiums and strong investment returns.2628
Q3 2024 - Net profit rose 5.9% to RMB38.3 billion as premiums and embedded value reached record highs.2628
H1 2024 - Net profit and assets hit record highs in 2024, with strong solvency and high dividends.2628
H2 2024